Form 4: Medpace Investors, LLC Sells 100,000 Shares of Medpace Holdings, Inc.

Medpace Investors, LLC, a 10% owner of Medpace Holdings, Inc., sold 100,000 shares of common stock over two days in March 2024.

Summary

• Medpace Investors, LLC, a significant shareholder of Medpace Holdings, Inc., reported the sale of 100,000 shares of common stock.
• The sales occurred on March 4 and March 5, 2024.
• On March 4, 2024, 50,000 shares were sold at a weighted average price of $403.12, with individual transactions ranging from $400.52 to $408.21.
• On March 5, 2024, another 50,000 shares were sold at a weighted average price of $402.70, with individual transactions ranging from $400.00 to $404.39.
• Following these transactions, Medpace Investors, LLC still beneficially owns 4,933,019 shares of Medpace Holdings, Inc.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, reporting the sale of shares by a major shareholder. It's a neutral event, neither particularly positive nor negative without further context.

Industry Context

Sales by major shareholders are common and can be driven by various factors, including portfolio diversification or personal financial needs. It's important to consider the context of these sales within the broader industry and company performance.

Stakeholder Impact

• The sale of shares could potentially create downward pressure on the stock price in the short term.
• Shareholders may interpret the sale as a lack of confidence by a major owner, although this is not necessarily the case.

Key Dates